AU2005304493B2 - Herbal composition PHY906 and its use in chemotherapy - Google Patents

Herbal composition PHY906 and its use in chemotherapy Download PDF

Info

Publication number
AU2005304493B2
AU2005304493B2 AU2005304493A AU2005304493A AU2005304493B2 AU 2005304493 B2 AU2005304493 B2 AU 2005304493B2 AU 2005304493 A AU2005304493 A AU 2005304493A AU 2005304493 A AU2005304493 A AU 2005304493A AU 2005304493 B2 AU2005304493 B2 AU 2005304493B2
Authority
AU
Australia
Prior art keywords
phy906
cpt
cancer
mice
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005304493A
Other languages
English (en)
Other versions
AU2005304493A1 (en
Inventor
Yung-Chi Cheng
Shwu-Huey Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU2005304493A1 publication Critical patent/AU2005304493A1/en
Application granted granted Critical
Publication of AU2005304493B2 publication Critical patent/AU2005304493B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2005304493A 2004-11-09 2005-11-09 Herbal composition PHY906 and its use in chemotherapy Expired AU2005304493B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62594304P 2004-11-09 2004-11-09
US60/625,943 2004-11-09
US11/100,433 2005-04-07
US11/100,433 US7534455B2 (en) 2000-03-09 2005-04-07 Herbal composition PHY906 and its use in chemotherapy
PCT/US2005/040605 WO2006053049A2 (en) 2004-11-09 2005-11-09 Herbal composition phy906 and its use in chemotherapy

Publications (2)

Publication Number Publication Date
AU2005304493A1 AU2005304493A1 (en) 2006-05-18
AU2005304493B2 true AU2005304493B2 (en) 2012-05-10

Family

ID=36337179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005304493A Expired AU2005304493B2 (en) 2004-11-09 2005-11-09 Herbal composition PHY906 and its use in chemotherapy

Country Status (8)

Country Link
US (1) US7534455B2 (enExample)
EP (1) EP1812028A4 (enExample)
JP (1) JP5057987B2 (enExample)
CN (2) CN104161832A (enExample)
AU (1) AU2005304493B2 (enExample)
CA (1) CA2583761C (enExample)
TW (1) TW200630105A (enExample)
WO (1) WO2006053049A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871279B2 (en) 2000-03-09 2014-10-28 Yale University Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen
US8394365B2 (en) * 2003-09-17 2013-03-12 Nektar Therapeutics Multi-arm polymer prodrugs
CN101730535A (zh) 2007-02-15 2010-06-09 耶鲁大学 草药组合物phy906及其在化疗中的用途
TWI361075B (en) * 2007-03-16 2012-04-01 Brion Res Inst Of Taiwan Pharmaceutical composition for inhibiting the syndrome of snore
CN101918017B (zh) * 2007-10-25 2013-07-31 植物药学公司 Phy906用于治疗炎性肠病和/或肠易激综合征的用途
US20130136811A1 (en) * 2010-05-26 2013-05-30 President And Fellows Of Harvard College Compositions and Methods for Pain Reduction
US8541382B2 (en) 2010-11-13 2013-09-24 Sirbal Ltd. Cardiac glycoside analogs in combination with emodin for cancer therapy
US8734859B1 (en) 2010-11-13 2014-05-27 Sirbal Ltd. Molecular combinations for cancer or other disease treatment
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US20170049687A1 (en) 2015-07-29 2017-02-23 Sirbal Ltd. Herbal Combinations For Treating Scalp Conditions
WO2015082950A1 (en) 2013-12-02 2015-06-11 Sirbal Ltd. Herbal combinations for treatment of a skin condition
CA3024301A1 (en) * 2016-05-23 2017-11-30 Yale University Improved therapeutic index of anti-immune checkpoint inhibitors using combination therapy comprising a phy906 extract, a scutellaria baicalensis georgi (s) extract or a compound from such extracts
SG11201901540UA (en) * 2016-06-22 2019-04-29 Univ Yale Mechanism based quality control for botanical medicine
US10086026B2 (en) 2016-06-27 2018-10-02 Uwais M. Syed Combined herbal and pharmaceutical composition and method
CN107970299A (zh) * 2017-11-16 2018-05-01 饶本强 一种清热解毒抗肿瘤复方制剂
KR102166949B1 (ko) * 2018-02-28 2020-10-16 중앙대학교 산학협력단 악액질 및 근손실 예방, 개선 또는 치료용 조성물
CN110105149B (zh) * 2019-04-23 2022-02-01 来宾市农业科学院 一种蚕沙防治甘蔗螟虫的方法
CN109991341B (zh) * 2019-05-17 2022-04-01 无限极（中国）有限公司 一种制首乌的质量检测方法
JP2023504202A (ja) * 2019-12-09 2023-02-01 イエール ユニバーシティ がんの再発を予防するための組成物および方法
TW202200183A (zh) * 2020-03-30 2022-01-01 耶魯大學 治療炎性和纖維化疾病和病症的方法
US12011284B2 (en) * 2020-05-19 2024-06-18 Peachy Corp. Systems and methods for preventing and treating wrinkles
TW202337484A (zh) * 2022-03-01 2023-10-01 耶魯大學 用於調節t細胞之活化t細胞核因子（nfat）活性的組成物及方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618495A (en) * 1982-08-25 1986-10-21 Tsumura Juntendo Inc. Preparation for reducing cancer symptoms without treating cancer
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US6048847A (en) * 1997-09-30 2000-04-11 Dabur Research Foundation Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
WO2001066123A2 (en) * 2000-03-09 2001-09-13 Yale University Composition consisting of phy906 and chemotherapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US6630176B2 (en) * 2000-03-07 2003-10-07 Mount Sinai School Of Medicine Of New York University Herbal remedies for treating allergies and asthma
WO2002007743A2 (de) * 2000-07-26 2002-01-31 Vitaplant Ag Piper methysticum pflanzenextrakt

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618495A (en) * 1982-08-25 1986-10-21 Tsumura Juntendo Inc. Preparation for reducing cancer symptoms without treating cancer
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US6048847A (en) * 1997-09-30 2000-04-11 Dabur Research Foundation Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
WO2001066123A2 (en) * 2000-03-09 2001-09-13 Yale University Composition consisting of phy906 and chemotherapeutic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LIU S-H et al., 'Developing PHY906 as a broad-spectrum modulator of chemotherapeutic agents in cancer therapy' Proceedings of the Annual Meeting of the American Association for Cancer Research, New York, US, 2005, 1 March 2004 Vol.45 pg128 *

Also Published As

Publication number Publication date
WO2006053049A2 (en) 2006-05-18
JP5057987B2 (ja) 2012-10-24
AU2005304493A1 (en) 2006-05-18
CN101098705A (zh) 2008-01-02
WO2006053049A3 (en) 2007-03-22
CN104161832A (zh) 2014-11-26
US20050196473A1 (en) 2005-09-08
EP1812028A2 (en) 2007-08-01
TW200630105A (en) 2006-09-01
JP2008519767A (ja) 2008-06-12
CA2583761C (en) 2015-04-21
EP1812028A4 (en) 2010-01-20
CA2583761A1 (en) 2006-05-18
US7534455B2 (en) 2009-05-19

Similar Documents

Publication Publication Date Title
CA2402466C (en) Composition consisting of phy906 and chemotherapeutic agents
CA2583761C (en) Herbal composition phy906 and its use in chemotherapy
US11452755B2 (en) Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome
US20130101688A1 (en) Herbal composition phy906 and its use in chemotherapy
US8871279B2 (en) Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen
Shen et al. Research and application of Radix Glycyrrhizae
AU2001245508B2 (en) Compositions consisting of PHY906 and chemotherapeutic agents
HK1111910A (en) Herbal composition phy906 and its use in chemotherapy
CN118806832B (zh) 一种用于晚期原发性肝癌的中药组合物及其应用
CN103585219B (zh) 一种阿尔泰狗娃花提取物在制备治疗艾滋病药物中的应用
CN119074858A (zh) 一种治疗白血病的组合物及其制备方法、应用
CN104510912B (zh) 一种治疗气滞血瘀型慢性乙型肝炎的中药及制备方法
CN114948873A (zh) 药物信息叠加扩增治疗系数的药物新制剂制备工艺与产品及用途
HK1077737A (en) Herbal composition phy906 and its use in chemotheraphy

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired